Management anticipates a 10% tariff reduction to improve profitability in the second half of 2026.
Nephros Inc. (NEPH) expects tariff relief to support margins later in 2026, reducing rates from 10% to a lower level. The company cited the change as a key driver for improved profitability in the second half of the year.
During its Q1 2026 earnings call, management did not provide specific guidance on the exact tariff reduction but emphasized its potential impact on cost structures. Prior tariff levels had pressured margins, and the anticipated relief aligns with broader industry trends.
No immediate market reaction was disclosed in the discussion.